Related Experiment Video
Updated: Jul 28, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones
1Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA. ecsanders@earthlink.net
Abstract:
Resistance to the quinolones almost always arises from the accumulation of mutations in chromosomal genes responsible for the drug targets, permeability, or active efflux. This resistance can be depicted as a stepwise process in which each step, represented by separate mutations, diminishes susceptibility on average 4- to 8-fold. The precise path followed in this stepwise process differs with the quinolone that selects resistance as well as the organism involved. At each step, the influence of each mutation on susceptibility to other quinolones not used in the selection process varies greatly, and a pattern of either cross-resistance or dichotomous resistance may be seen. From an understanding of the stepwise process by which resistance to the quinolones evolves, it is possible to use an 8-fold rule to predict which compounds may provide effective therapy for a given infection and be least likely to select for resistance.
Insights
Quinolone resistance develops through stepwise mutations affecting drug targets, permeability, or efflux. Understanding this process allows prediction of effective therapies using an 8-fold rule to minimize resistance selection.
Area of Science:
- Microbiology
- Pharmacology
- Genetics
Background:
- Quinolone antibiotics are crucial for treating bacterial infections.
- Resistance to quinolones is a growing public health concern.
- Mechanisms of resistance involve mutations in chromosomal genes.
Purpose of the Study:
- To elucidate the stepwise process of quinolone resistance development.
- To identify patterns of cross-resistance and dichotomous resistance.
- To develop a predictive rule for selecting effective quinolones and minimizing resistance.
Main Methods:
- Analysis of mutation accumulation in bacterial chromosomal genes.
- Quantification of susceptibility changes (4- to 8-fold) per mutation step.
- Examination of cross-resistance patterns with different quinolones.
- Evaluation of organism- and quinolone-specific resistance pathways.
Main Results:
- Quinolone resistance evolves via a stepwise accumulation of mutations.
- Each mutation typically reduces susceptibility by 4- to 8-fold.
- Resistance pathways vary significantly based on the quinolone and organism.
- Observed patterns include cross-resistance and dichotomous resistance.
Conclusions:
- Understanding the stepwise evolution of quinolone resistance is key.
- An '8-fold rule' can predict effective therapies and minimize resistance.
- This knowledge aids in optimizing antibiotic treatment strategies.
Related Concept Videos
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis

